McElvaney, Noel G., Burdon, Jonathan, Seersholm, Niels, Altraja, Alan, Mäkitaro, Riita, Chorostowska-Wynimko, Joanna, Sanak, Marek, Stoicescu, Paul I., Piitulainen, Eeva, Vit, Oliver, Wencker, Marion, Tortorici, Michael A., Holmes, Mark, Fries, Michael, Edelman, Jonathan M., Chapman, Kenneth R., Glanville, Allan, Wark, Peter A. B., Thompson, Philip J., Hernandez, Paul, Chlumsky, Jan, Teschler, Helmut, Ficker, Joachim H.. Lancet Publishing; 2017. Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE).

Chen, Wenjia, Tran, Trung N., Alacqua, Marianna, Al-Ahmad, Mona, Altraja, Alan, Al-Lehebi, Riyad, Bhutani, Mohit, Bjermer, Leif, Bjerrum, Anne-Sofie, Bourdin, Arnaud, von Bülow, Anna, Busby, John, Sadatsafavi, Mohsen, Walter Canonica, Giorgio, Carter, V, Christoff, GC, Cosio, BG, Costello, RW, Fonseca, JA, Gibson, Peter G., Yoo, K-H, Heaney, LG, Heffler, E, Murray, Ruth, Hew, M, Hilberg, O, Hoyte, F, Iwanaga, T, Jackson, DJ, Jones, RC, Koh, MS, Kuna, P, Larenas-Linnemann, D, Lehmann, S, Wong, Nigel Chong Boon, Lehtimäki, L, Lyu, J, Mahboub, B, Maspero, J, Menzies-Gow, AN, Newell, A, Sirena, C, Papadopoulos, NG, Papaioannou, AI, Perez-de-Llano, L, Ali, Nasloon, Perng Steve, D-W, Peters, M, Pfeffer, PE, Porsbjerg, CM, Popov, TA, Rhee, CK, Salvi, S, Taillé, C, Taube, C, Torres-Duque, CA, Ariti, Con, Ulrik, C, Ra, S-W, Wang, E, Wechsler, ME, Price, DB, Bulathsinhala, Lakmini, Gil, Esther Garcia, FitzGerald, J. Mark. Elsevier; 2023. Impact of initiatinG bioLogics In patients with severe asThma on long-Term OCS or frEquent Rescue steroids (GLITTER): data from the International Severe Asthma Registry.

Pfeffer, Paul E., Ali, Nasloon, Altraja, Alan, Lehtimäki, Lauri, Papadopoulos, Nikolaos G., Salvi, Sundeep, Costello, Richard W., Cushen, Breda, Heffler, Enrico, Iwanaga, Takashi, Al-Ahmad, Mona, Larenas-Linnemann, Désirée, Murray, Ruth, Gibson, Peter G., Fonseca, JA, Al-Lehebi, R, Rhee, CK, Perez-de-Llano, L, Perng Steve, D-W, Mahboub, B, Wang, E, Goh, C, Lyu, J, Ulrik, Charlotte, Newell, A, Alacqua, M, Belevskiy, AS, Bhutani, M, Bjermer, L, Bjornsdottir, U, Bourdin, A, Bulow, AV, Busby, J, Canonica, GW, Tran, Trung N., Cosio, BG, Dorscheid, DR, Muñoz-Esquerre, M, FitzGerald, JM, Gil, EG, Gibson, PG, Heaney, LG, Hew, M, Hilberg, O, Hoyte, F, Maspero, Jorge, Jackson, DJ, Koh, MS, Ko, H-KB, Lee, JH, Lehmann, S, Chaves Loureiro, C, Lúðvíksdóttir, D, Menzies-Gow, AN, Mitchell, P, Papaioannou, AI, Peters, Matthew, Popov, TA, Porsbjerg, CM, Salameh, L, Sirena, C, Taillé, C, Taube, C, Tohda, Y, Wechsler, ME, Price, DB, Christoff, George C., Sadatsafavi, Mohsen, Torres-Duque, Carlos A.. John Wiley & Sons; 2023. Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both.